LXEO – lexeo therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

LXEO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

4/9

05:48 pm

lxeo

Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Otero Jose Manuel

High Report

Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Otero Jose Manuel

Report

4/9

05:46 pm

lxeo

Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Robertson Jenny

High Report

Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Robertson Jenny

Report

4/9

05:45 pm

lxeo

Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: See Tai Sandi

High Report

Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: See Tai Sandi

Report

4/7

06:07 am

lxeo

Form 8-K Lexeo Therapeutics, Inc. For: Apr 07

High Report

Form 8-K Lexeo Therapeutics, Inc. For: Apr 07

Report

4/1

07:58 pm

lxeo

Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Townsend Richard Nolan

Low Report

Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Townsend Richard Nolan

Report

3/24

04:17 pm

lxeo

Form S-8 POS Lexeo Therapeutics, Inc.

High Report

Form S-8 POS Lexeo Therapeutics, Inc.

Report

3/24

07:52 am

lxeo

Form 424B5 Lexeo Therapeutics, Inc.

High Report

Form 424B5 Lexeo Therapeutics, Inc.

Report

3/24

07:05 am

lxeo

Form S-8 Lexeo Therapeutics, Inc.

High Report

Form S-8 Lexeo Therapeutics, Inc.

Report

3/24

07:03 am

lxeo

Form 10-K Lexeo Therapeutics, Inc. For: Dec 31

High Report

Form 10-K Lexeo Therapeutics, Inc. For: Dec 31

Report

3/24

07:02 am

lxeo

Form 8-K Lexeo Therapeutics, Inc. For: Mar 24

High Report

Form 8-K Lexeo Therapeutics, Inc. For: Mar 24

Report

2/21

05:10 pm

lxeo

Form 4 Lexeo Therapeutics, Inc. For: Feb 19 Filed by: Townsend Richard Nolan

Medium Report

Form 4 Lexeo Therapeutics, Inc. For: Feb 19 Filed by: Townsend Richard Nolan

Report

2/21

05:09 pm

lxeo

Form 4 Lexeo Therapeutics, Inc. For: Feb 19 Filed by: See Tai Sandi

Medium Report

Form 4 Lexeo Therapeutics, Inc. For: Feb 19 Filed by: See Tai Sandi

Report

2/21

05:09 pm

lxeo

Form 4 Lexeo Therapeutics, Inc. For: Feb 19 Filed by: Adler Eric

Medium Report

Form 4 Lexeo Therapeutics, Inc. For: Feb 19 Filed by: Adler Eric

Report

2/21

05:09 pm

lxeo

Form 4 Lexeo Therapeutics, Inc. For: Feb 19 Filed by: Robertson Jenny

Medium Report

Form 4 Lexeo Therapeutics, Inc. For: Feb 19 Filed by: Robertson Jenny

Report

2/19

04:25 pm

lxeo

Form 144 Lexeo Therapeutics, Inc. Filed by: Townsend Richard Nolan

Medium Report

Form 144 Lexeo Therapeutics, Inc. Filed by: Townsend Richard Nolan

Report

2/19

04:20 pm

lxeo

Form 144 Lexeo Therapeutics, Inc. Filed by: Robertson Jenny

Medium Report

Form 144 Lexeo Therapeutics, Inc. Filed by: Robertson Jenny

Report

2/19

04:16 pm

lxeo

Form 144 Lexeo Therapeutics, Inc. Filed by: See Tai Sandi

Medium Report

Form 144 Lexeo Therapeutics, Inc. Filed by: See Tai Sandi

Report

2/19

04:07 pm

lxeo

Form 144 Lexeo Therapeutics, Inc. Filed by: Adler Eric

Medium Report

Form 144 Lexeo Therapeutics, Inc. Filed by: Adler Eric

Report

2/14

12:04 pm

lxeo

Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC

Low Report

Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC

Report

2/14

11:55 am

lxeo

Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC

Low Report

Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC

Report

2/14

09:00 am

lxeo

Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Omega Fund VI, L.P.

Medium Report

Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Omega Fund VI, L.P.

Report

2/13

10:25 am

lxeo

Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: MIZUHO FINANCIAL GROUP INC

Medium Report

Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: MIZUHO FINANCIAL GROUP INC

Report

2/12

09:35 am

lxeo

Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Adage Capital Management, L.P.

Medium Report

Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Adage Capital Management, L.P.

Report

2/4

03:46 pm

lxeo

Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: BlackRock, Inc.

Low Report

Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: BlackRock, Inc.

Report

1/22

04:55 pm

lxeo

Form 4 Lexeo Therapeutics, Inc. For: Jan 17 Filed by: Rasbach Kyle

High Report

Form 4 Lexeo Therapeutics, Inc. For: Jan 17 Filed by: Rasbach Kyle

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.